Neovasc Inc (US) (NVCN) Earns Daily News Impact Score of 0.09

News articles about Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) have trended somewhat positive on Monday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neovasc Inc (US) earned a news impact score of 0.09 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 46.4378014164988 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

These are some of the news stories that may have impacted Accern Sentiment’s scoring:

How to Become a New Pot Stock Millionaire

Shares of Neovasc Inc (US) stock remained flat at $$0.06 during trading on Monday. The stock had a trading volume of 316,802,783 shares, compared to its average volume of 40,745,016. The firm has a market cap of $29.17, a price-to-earnings ratio of -0.18 and a beta of 1.23. The company has a current ratio of 0.77, a quick ratio of 0.75 and a debt-to-equity ratio of -0.89. Neovasc Inc has a fifty-two week low of $0.03 and a fifty-two week high of $1.89.

Several brokerages have recently issued reports on NVCN. Zacks Investment Research lowered Neovasc Inc (US) from a “hold” rating to a “sell” rating in a report on Thursday. Canaccord Genuity reduced their price target on Neovasc Inc (US) from $1.05 to $0.50 and set a “buy” rating for the company in a report on Thursday, March 29th. Leerink Swann reduced their price target on Neovasc Inc (US) from $5.00 to $2.00 and set an “outperform” rating for the company in a report on Thursday, March 29th. Finally, ValuEngine lowered Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a report on Sunday, December 31st.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3344080/neovasc-inc-us-nvcn-earns-daily-news-impact-score-of-0-09.html.

Neovasc Inc (US) Company Profile

Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.

Insider Buying and Selling by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)

Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

TT Electronics  To Go Ex-Dividend on April 26th
TT Electronics To Go Ex-Dividend on April 26th
Woodward  Stock Rating Upgraded by Zacks Investment Research
Woodward Stock Rating Upgraded by Zacks Investment Research
Albireo Pharma  Earns Outperform Rating from Wedbush
Albireo Pharma Earns Outperform Rating from Wedbush
Banner  Downgraded by Zacks Investment Research to “Sell”
Banner Downgraded by Zacks Investment Research to “Sell”
ManpowerGroup  Stock Rating Reaffirmed by SunTrust Banks
ManpowerGroup Stock Rating Reaffirmed by SunTrust Banks
First Community  Rating Increased to Buy at Zacks Investment Research
First Community Rating Increased to Buy at Zacks Investment Research


Leave a Reply

© 2006-2018 Ticker Report. Google+.